A detailed history of Jane Street Group, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 2,069,568 shares of DNA stock, worth $724,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,069,568
Previous 3,651,192 43.32%
Holding current value
$724,348
Previous $6.17 Million 61.1%
% of portfolio
0.0%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.06 - $1.67 $1.68 Million - $2.64 Million
-1,581,624 Reduced 43.32%
2,069,568 $2.4 Million
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $2.55 Million - $3.62 Million
2,022,281 Added 124.15%
3,651,192 $6.17 Million
Q3 2023

Nov 14, 2023

SELL
$1.61 - $2.54 $346,887 - $547,263
-215,458 Reduced 11.68%
1,628,911 $2.95 Million
Q2 2023

Aug 14, 2023

BUY
$1.14 - $1.95 $405,785 - $694,106
355,952 Added 23.91%
1,844,369 $3.43 Million
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $1.23 Million - $2.25 Million
1,025,838 Added 221.76%
1,488,417 $1.98 Million
Q4 2022

Feb 14, 2023

SELL
$1.63 - $3.52 $343,406 - $741,590
-210,679 Reduced 31.29%
462,579 $781,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $321,738 - $1.65 Million
440,738 Added 189.55%
673,258 $2.1 Million
Q2 2022

Aug 16, 2022

BUY
$2.2 - $4.2 $377,590 - $720,854
171,632 Added 281.88%
232,520 $553,000
Q1 2022

May 17, 2022

SELL
$2.83 - $8.69 $337,265 - $1.04 Million
-119,175 Reduced 66.19%
60,888 $245,000
Q4 2021

Feb 15, 2022

BUY
$8.31 - $14.92 $1.35 Million - $2.42 Million
161,920 Added 892.47%
180,063 $1.5 Million
Q3 2021

Nov 16, 2021

BUY
$9.15 - $13.28 $166,008 - $240,939
18,143 New
18,143 $210,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $451M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.